SCHEMBL21704881

SCHEMBL21704881

COc1cc(OC)cc(-c2c3c(c(-c4cc(OC)cc(OC)c4)c4cc5ccccc5cc24)-c2ccc4c5ccc6c7c(ccc(c8ccc-3c2c84)c57)c2c(-c3ccccc3)c3cccc4c5ccccc5c(c34)c62)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.37
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 4/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2B6 P20813 3/20 0.37
AHR P35869 2/20 0.37
NR1I3 Q14994 2/20 0.37
VDR P11473 1/20 0.37
CYP2D6 P10635 3/20 0.36
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2E1 P05181 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP4B1 P13584 1/20 0.36
CYP3A5 P20815 1/20 0.36
CYP2A7 P20853 1/20 0.36
CYP3A7 P24462 1/20 0.36
CYP2F1 P24903 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21704888 0.85 SMN1; SMN2 (0.40) GPR84CYP1A2CYP3A4AHRCYP2D6
SCHEMBL21705104 0.83 ESR1 (0.34)
SCHEMBL12567487 0.83 CASP3 (0.39) GPR84CYP1A2CYP3A4CYP2C9CYP2B6
SCHEMBL21705051 0.82 GPR84 (0.35) GPR84CYP1A2CYP3A4CYP2C9CYP1A1
SCHEMBL21699100 0.81 SMN1; SMN2 (0.37) GPR84CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL21704893 0.80 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C9AHRCYP2C19
SCHEMBL21705078 0.80 ABCG2 (0.34) CYP1A2CYP3A4CYP2C9CYP2D6CYP2C19
SCHEMBL21704887 0.79 CYP1A2 (0.36) CYP1A2CYP3A4CYP2C9AHRCYP1A1
SCHEMBL21705052 0.79 ESR1 (0.32)
SCHEMBL21704897 0.78 ESR1 (0.35) CYP1A2AHRCYP1A1CYP1B1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object CANON KABUSHIKI KAISHA (JP) 2022-06-28 US disclosed
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT CANON KABUSHIKI KAISHA (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT OCIAD1, L1CAM, SPIN4 GPR84 334/4885CYP1A2 1327/4885CYP3A4 303/4885
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object OCIAD1, L1CAM, SPIN4 GPR84 334/4885CYP1A2 1327/4885CYP3A4 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.